Chair: Robert Ritzel (GER) 15:00 – 15:20 The Practical Challenges of Common Insulin Escalation Strategies Rory McCrimmon (UK) 15:20 – 15:40 Basal Insulin/GLP-1 RA Fixed-Ratio
Chair: Rodolfo Galindo (USA) 15:30 – 15:35 Welcome and Baseline Polling Rodolfo Galindo (USA) 15:35 – 15:55 Tracking the Evolution of Insulin and the Impetus
Chair: Hiddo Lambers Heerspink (NLD) 15:30 – 15:35 Chair welcome and introductions Hiddo Lambers Heerspink (NLD) 15:35 – 15:55 Cellular energetics and the positive impact
Chair: Alice Cheng (CAN) 16:00 – 16:08 Welcome, introduction to faculty and the patient story Alice Cheng (CAN) 16:08 – 16:16 It’s not too early
Chair: Lala Leelarathna (UK) 16:00 – 16:23 Importance of Diabetes Technology Meeting People’s Needs & Value of Pod Therapy Torben Biester (GER) 16:23 – 16:30
Chair: Richard Bergenstal (USA), Bernhard Kulzer (GER) 16:00 – 16:05 Introduction Richard Bergenstal (USA)Bernhard Kulzer (GER) 16:05 – 16:30 How effective is a digital logbook
Chair: Banshi Saboo (IND) 16:30 – 16:35 Welcome and Introduction Banshi Saboo (IND) 16:36 – 16:51 Early combination therapy – Evidence form Asia Manoj Chawla
Chair: Partha Kar (UK) 17:00 – 18:00 Should Faster Rapid-Acting Insulins be the standard for first line therapy? Matthias Weber (GER)Thomas Haak (GER)Partha Kar (UK)Emma
